Printer Friendly

Terumo to Make Full Entry into Market for Catheter-based Treatment for Cerebral Vascular Disease.

Tokyo, Japan, Mar 1, 2006 - (JCN) - Terumo has signed an agreement with MicroVention of California, whereby Terumo will acquire the US company as its wholly owned subsidiary by the end of March.

MicroVention specializes in the production of hydrogel-coated and bare platinum coils for the treatment of cerebral vascular aneurysms, and has about a 15% share of the global market.

With the US company under its arm, Terumo aims to make a full entry into the field of catheter-based treatment for cerebral vascular diseases.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Mar 3, 2006
Words:94
Previous Article:ANA to Introduce "Euphony ANA Audio" Technology for In-Flight Entertainment.
Next Article:Info Plant Survey: When - and How Often - Do Japanese Consumers Frequent Department Stores?


Related Articles
Goodman to Exclusively Distribute Embolic Coils from Micrus Endovascular.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters